rs56199702

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2

The NM_000165.5(GJA1):​c.-16-12T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0063 in 1,546,168 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0056 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0064 ( 59 hom. )

Consequence

GJA1
NM_000165.5 intron

Scores

2
Splicing: ADA: 0.9992
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 1.57

Publications

3 publications found
Variant links:
Genes affected
GJA1 (HGNC:4274): (gap junction protein alpha 1) This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. The encoded protein is the major protein of gap junctions in the heart that are thought to have a crucial role in the synchronized contraction of the heart and in embryonic development. A related intronless pseudogene has been mapped to chromosome 5. Mutations in this gene have been associated with oculodentodigital dysplasia, autosomal recessive craniometaphyseal dysplasia and heart malformations. [provided by RefSeq, May 2014]
GJA1 Gene-Disease associations (from GenCC):
  • hypoplastic left heart syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • oculodentodigital dysplasia
    Inheritance: AD, SD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant palmoplantar keratoderma and congenital alopecia
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, G2P
  • erythrokeratodermia variabilis et progressiva 3
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • oculodentodigital dysplasia, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • craniometaphyseal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • erythrokeratodermia variabilis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • syndactyly type 3
    Inheritance: AD, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Hallermann-Streiff syndrome
    Inheritance: AR Classification: LIMITED Submitted by: G2P
  • craniometaphyseal dysplasia, autosomal recessive
    Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 6-121446820-T-A is Benign according to our data. Variant chr6-121446820-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 355158.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00558 (850/152306) while in subpopulation NFE AF = 0.0094 (639/67996). AF 95% confidence interval is 0.00879. There are 8 homozygotes in GnomAd4. There are 398 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 Unknown,AD,AR,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GJA1NM_000165.5 linkc.-16-12T>A intron_variant Intron 1 of 1 ENST00000282561.4 NP_000156.1 P17302A0A654IBU3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GJA1ENST00000282561.4 linkc.-16-12T>A intron_variant Intron 1 of 1 1 NM_000165.5 ENSP00000282561.3 P17302
GJA1ENST00000647564.1 linkc.-16-12T>A intron_variant Intron 1 of 1 ENSP00000497565.1 P17302
GJA1ENST00000649003.1 linkc.-16-12T>A intron_variant Intron 1 of 1 ENSP00000497283.1 P17302
GJA1ENST00000650427.1 linkc.-16-12T>A intron_variant Intron 1 of 1 ENSP00000497367.1 P17302

Frequencies

GnomAD3 genomes
AF:
0.00559
AC:
850
AN:
152188
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00960
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00940
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00573
AC:
1433
AN:
250014
AF XY:
0.00571
show subpopulations
Gnomad AFR exome
AF:
0.00112
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00258
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0108
Gnomad NFE exome
AF:
0.00911
Gnomad OTH exome
AF:
0.00687
GnomAD4 exome
AF:
0.00638
AC:
8894
AN:
1393862
Hom.:
59
Cov.:
26
AF XY:
0.00638
AC XY:
4451
AN XY:
697682
show subpopulations
African (AFR)
AF:
0.00118
AC:
38
AN:
32210
American (AMR)
AF:
0.00280
AC:
125
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.00214
AC:
55
AN:
25716
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39366
South Asian (SAS)
AF:
0.000130
AC:
11
AN:
84936
European-Finnish (FIN)
AF:
0.0111
AC:
590
AN:
53390
Middle Eastern (MID)
AF:
0.000705
AC:
4
AN:
5672
European-Non Finnish (NFE)
AF:
0.00738
AC:
7748
AN:
1049864
Other (OTH)
AF:
0.00556
AC:
323
AN:
58062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
472
945
1417
1890
2362
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00558
AC:
850
AN:
152306
Hom.:
8
Cov.:
32
AF XY:
0.00534
AC XY:
398
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41586
American (AMR)
AF:
0.00196
AC:
30
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00960
AC:
102
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00940
AC:
639
AN:
67996
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
46
93
139
186
232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00917
Hom.:
4
Bravo
AF:
0.00429

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GJA1: BS2 -

Hypoplastic left heart syndrome 1 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Oculodentodigital dysplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Syndactyly type 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
14
DANN
Benign
0.76
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.91
SpliceAI score (max)
0.99
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.99
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56199702; hg19: chr6-121767966; API